Patents by Inventor Rahul C. Mehta
Rahul C. Mehta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20150257991Abstract: A method for the modification of melanin distribution, and the composition thereof to modify melanin distribution are disclosed. A method for the reduction of melanin distribution, and the composition thereof to reduce melanin distribution are disclosed. A representative composition comprises 4-ethoxybenzaldehyde and one or more additional active agents as well as a pharmaceutically acceptable carrier or excipient. Carriers and excipients may be formulated for topical administration. Compositions may also be formulated for transdermal administration. The compositions may be used for the prevention and treatment of pigmentation disorders, by way of non-limited example, post-inflammatory hyperpigmentation and others. The compositions may be used for lightening skin.Type: ApplicationFiled: June 1, 2015Publication date: September 17, 2015Inventors: Rahul C. Mehta, Elizabeth Tsin Ho Makino, Sujatha D. Sonti, John A. Garruto
-
Patent number: 9044404Abstract: A method for the modification of melanin distribution, and the composition thereof to modify melanin distribution are disclosed. A method for the reduction of melanin distribution, and the composition thereof to reduce melanin distribution are disclosed. A representative composition comprises 4-ethoxybenzaldehyde and one or more additional active agents as well as a pharmaceutically acceptable carrier or excipient. Carriers and excipients may be formulated for topical administration. Compositions may also be formulated for transdermal administration. The compositions may be used for the prevention and treatment of pigmentation disorders, by way of non-limited example, post-inflammatory hyperpigmentation and others. The compositions may be used for lightening skin.Type: GrantFiled: February 26, 2013Date of Patent: June 2, 2015Assignee: Allergan, Inc.Inventors: Rahul C. Mehta, Elizabeth Tsin Ho Makino, Sujatha D. Sonti, John A. Garruto
-
Patent number: 8865138Abstract: A method for the modification of melanin distribution, and the composition thereof to modify melanin distribution are disclosed. A method for the reduction of melanin distribution, and the composition thereof to reduce melanin distribution are disclosed. A representative composition comprises 4-ethoxybenzaldehyde and one or more additional active agents as well as a pharmaceutically acceptable carrier or excipient. Carriers and excipients may be formulated for topical administration. Compositions may also be formulated for transdermal administration. The compositions may be used for the prevention and treatment of pigmentation disorders, by way of non-limited example, post-inflammatory hyperpigmentation and others. The compositions may be used for lightening skin.Type: GrantFiled: June 25, 2012Date of Patent: October 21, 2014Assignee: Allergan, Inc.Inventors: Rahul C. Mehta, Elizabeth Tsin Ho Makino, Sujatha D. Sonti, John A. Garruto
-
Patent number: 8778315Abstract: A method for the modification of melanin distribution, and the composition thereof to modify melanin distribution are disclosed. A method for the reduction of melanin distribution, and the composition thereof to reduce melanin distribution are disclosed. A representative composition comprises 4-ethoxybenzaldehyde and one or more additional active agents as well as a pharmaceutically acceptable carrier or excipient. Carriers and excipients may be formulated for topical administration. Compositions may also be formulated for transdermal administration. The compositions may be used for the prevention and treatment of pigmentation disorders, by way of non-limited example, post-inflammatory hyperpigmentation and others. The compositions may be used for lightening skin.Type: GrantFiled: February 26, 2013Date of Patent: July 15, 2014Assignee: Allergan, Inc.Inventors: Rahul C. Mehta, Elizabeth Tsin Ho Makino, Sujatha D. Sonti, John A. Garruto
-
Publication number: 20130034510Abstract: A method for the modification of melanin distribution, and the composition thereof to modify melanin distribution are disclosed. A method for the reduction of melanin distribution, and the composition thereof to reduce melanin distribution are disclosed. A representative composition comprises 4-ethoxybenzaldehyde and one or more additional active agents as well as a pharmaceutically acceptable carrier or excipient. Carriers and excipients may be formulated for topical administration. Compositions may also be formulated for transdermal administration. The compositions may be used for the prevention and treatment of pigmentation disorders, by way of non-limited example, post-inflammatory hyperpigmentation and others. The compositions may be used for lightening skin.Type: ApplicationFiled: June 25, 2012Publication date: February 7, 2013Applicant: SkinMedica, Inc.Inventors: Rahul C. MEHTA, Elizabeth Tsin Ho Makino, Sujatha D. Sonti, John A. Garruto
-
Patent number: 8236288Abstract: A method for the modification of melanin distribution, and the composition thereof to modify melanin distribution are disclosed. A method for the reduction of melanin distribution, and the composition thereof to reduce melanin distribution are disclosed. A representative composition comprises 4-ethoxybenzaldehyde and one or more additional active agents as well as a pharmaceutically acceptable carrier or excipient. Carriers and excipients may be formulated for topical administration. Compositions may also be formulated for transdermal administration. The compositions may be used for the prevention and treatment of pigmentation disorders, by way of non-limited example, post-inflammatory hyperpigmentation and others. The compositions may be used for lightening skin.Type: GrantFiled: January 6, 2012Date of Patent: August 7, 2012Assignee: Skinmedica, Inc.Inventors: Rahul C. Mehta, Elizabeth Tsin Ho Makino, Sujatha D. Sonti, John A. Garruto
-
Publication number: 20120177586Abstract: A method for the modification of melanin distribution, and the composition thereof to modify melanin distribution are disclosed. A method for the reduction of melanin distribution, and the composition thereof to reduce melanin distribution are disclosed. A representative composition comprises 4-ethoxybenzaldehyde and one or more additional active agents as well as a pharmaceutically acceptable carrier or excipient. Carriers and excipients may be formulated for topical administration. Compositions may also be formulated for transdermal administration. The compositions may be used for the prevention and treatment of pigmentation disorders, by way of non-limited example, post-inflammatory hyperpigmentation and others. The compositions may be used for lightening skin.Type: ApplicationFiled: January 6, 2012Publication date: July 12, 2012Applicant: SkinMedica, Inc.Inventors: Rahul C. MEHTA, Elizabeth Tsin Ho MAKINO, Sujatha D. SONTI, John A. GARRUTO
-
Publication number: 20110213014Abstract: The present invention relates to compositions and methods which enhance the delivery of oligonucleotides and other nucleosidic moieties via topical routes of administration. Preferred compositions include liposomes or penetration enhancers for the delivery of such moieties to dermal and/or epidermal tissue in an animal for investigative, therapeutic or prophylactic purposes.Type: ApplicationFiled: May 13, 2011Publication date: September 1, 2011Applicant: Isis Pharmaceuticals, Inc.Inventors: Rahul C. Mehta, Gregory E. Hardee, Phillip Dan Cook, David J. Ecker, Yali Jennifer Tsai, Michael V. Templin
-
Patent number: 7964579Abstract: The present invention relates to compositions and methods which enhance the delivery of oligonucleotides and other nucleosidic moieties via topical routes of administration. Preferred compositions include liposomes or penetration enhancers for the delivery of such moieties to dermal and/or epidermal tissue in an animal for investigative, therapeutic or prophylactic purposes.Type: GrantFiled: August 21, 2009Date of Patent: June 21, 2011Assignee: Isis Pharmaceuticals, Inc.Inventors: Rahul C. Mehta, Gregory E. Hardee, Phillip Dan Cook, David J. Ecker, Yali Jennifer Tsai, Michael V. Templin
-
Publication number: 20090326045Abstract: The present invention relates to compositions and methods which enhance the delivery of oligonucleotides and other nucleosidic moieties via topical routes of administration. Preferred compositions include liposomes or penetration enhancers for the delivery of such moieties to dermal and/or epidermal tissue in an animal for investigative, therapeutic or prophylactic purposes.Type: ApplicationFiled: August 21, 2009Publication date: December 31, 2009Applicant: Isis Pharmaceuticals, Inc.Inventors: Rahul C. Mehta, Gregory E. Hardee, Phillip Dan Cook, David J. Ecker, Yali Jennifer Tsai, Michael V. Templin
-
Patent number: 6841539Abstract: The present invention relates to compositions and methods which enhance the delivery of oligonucleotides and other nucleosidic moieties via topical routes of administration. Preferred compositions include liposomes or penetration enhancers for the delivery of such moieties to dermal and/or epidermal tissue in an animal for investigative, therapeutic or prophylactic purposes.Type: GrantFiled: May 20, 1999Date of Patent: January 11, 2005Assignee: ISIS Pharmaceuticals, Inc.Inventors: Rahul C. Mehta, Gregory E. Hardee, Phillip Dan Cook, David J. Ecker, Yali Jennifer Tsai, Michael V. Templin
-
Publication number: 20030027780Abstract: The present invention is related to non-parenteral multiparticulate formulations capable of transporting therapeutic, prophylactic and diagnostic agents across mucosal membranes such as gastrointestinal, buccal, nasal, rectal and vaginal. Formulations comprise a plurality of carrier particles, an agent to be delivered across a mucosal membrane, and a penetration enhancer. The drug is adhered to the surface of the carrier particle or is impregnated within by electrostatic, covalent or mechanical forces.Type: ApplicationFiled: February 8, 2002Publication date: February 6, 2003Inventors: Gregory E. Hardee, Lloyd G. Tillman, Maria Gonzalez-Ferreiro, Rahul C. Mehta, Ching-Leou Teng
-
Patent number: 6083923Abstract: Pharmaceutical compositions comprising sterically stabilized liposomes containing antisense oligonucleotides are provided for the modulation of expression of the human ras gene in both the normal (wildtype) and activated (mutant) forms.Type: GrantFiled: October 31, 1997Date of Patent: July 4, 2000Assignee: Isis Pharmaceuticals Inc.Inventors: Gregory E. Hardee, Richard S. Geary, Arthur Levin, Michael V. Templin, Randy Howard, Rahul C. Mehta